Peptisystems AB is a medical technology manufacturer based in Uppsala, specializing in the development and production of peptide and oligonucleotide synthesizers. The company focuses on providing synthesis solutions that support therapeutic development, emphasizing innovations that enhance the efficiency and effectiveness of the synthesis process. Their synthesizers are designed to facilitate easy scale-up, allowing for seamless transitions from research to larger-scale production.
The company is committed to improving control over synthesis processes while aiming to reduce process mass intensity (PMI). This focus on optimization is part of their broader goal to represent a new generation of synthesizer technology that meets the evolving needs of the pharmaceutical industry. Peptisystems AB boasts an experienced team with a rich history in the field, which supports their dedication to innovation in therapeutic production.